Investors in Healthcare and Biotech

The Morningside Group Limited is a private equity and venture capital firm specializing in early stage. It seeks to make investments in machinery manufacturing, high-tech, life science companies formed around new technologies, media, the Internet, biotechnology, telecommunication, life science, entertainment, consumer, education, and clean tech sectors. It seeks to invest in companies based in North America, Europe, and Asia Pacific, where its particular focus is on China. The Morningside Group Limited was founded in 1986 and is based Hong Kong with additional offices in Shanghai, China; Beijing, China; and Boston, United States.

Versant Ventures is a leading healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great companies. The firm invests across the healthcare sector and at all stages of company development, with an emphasis on the discovery and development of novel therapeutics. With $2.3 billion under management and offices in Canada, the U.S. and Europe, Versant has built a team with deep investment, operating, and scientific expertise that enables a hands-on approach to company building. Since the firm’s founding in 1999, more than 65 Versant companies have achieved successful acquisitions or IPOs.

Lilly Asian Ventures makes venture capital investments in Asia for Eli Lilly and Company, a global innovation-driven pharmaceutical company. Lilly Asian Ventures invests in promising life science companies with strong management teams and innovative technology and/or business models. Their initial focus will be primarily on opportunities in China, although they will consider investment opportunities elsewhere in east and south Asia.

SOSV is venture capital firm and an accelerator specializing in technology startups. The firm also specializes in seed, early venture, growth capital, venture and growth-stage funding to disruptive startups. The firm typically invests in information technology with a focus on hardware, software, leap motion, sales and biotechnology, telecommunications, energy efficiency technology, energy, green energy, medical devices, transportation, robotics, internet, and social media; it also invests in the food sector. It seeks to invest globally with a focus on United States, Europe, and Asia including China. The firm typically invests between $0.01 million and $0.05 million and offers a two-four month program in exchange for equity. The firm prefers to invest as the lead investor. SOSV was founded in 1995 and is based in Princeton, New Jearsey with additional offices in United States of America, Europe, and Asia.

Qiming Venture Partners invests in young, fast-growing companies across China in the media and internet, IT, consumer and retail, healthcare, and clean technology sectors. we are early to growth stage venture capital firm with offices in Shanghai, Beijing and Hong Kong. Since their debut in 2006, we have established their selves as a leading investment firm in China and currently manage four funds with over $1 billion in assets.

We’re (not just) investors. We’re (more than) advisors. We’re (beyond) connectors. Ben Franklin Technology Partners combines the best practices of early stage investing with a higher purpose – to lead the region’s technology community to new heights, creating jobs and transforming lives. For over 30 years, Ben has been the leading seed stage capital provider for the region’s technology sectors, investing over $170 million in more than 1,750 regional technology companies, many of which have gone on to become industry leaders. Ben Franklin has also launched university/industry partnerships that accelerate scientific discoveries to commercialization, and has seeded regional initiatives that strengthen our entrepreneurial community.

New Alliance Capital is a venture capital and private equity firm that specializes in early, growth stage and pre-IPO investments. It primarily invest in high-end manufacturing, technology, advanced agriculture, consumer goods, information, media, energy, recycling, environmental protection, and modern services industry sectors. New Alliance Capital typically invests between $4.71 million and $31.41 million. Qu Liefeng founded it in 2008, with its headquarters in Shanghai in China.

IMM Investment Corp. is a private equity and venture capital firm specializing in mezzanine investments. It focuses on mergers and acquisitions, venture capital investing, corporate restructuring, private equity investing, industry consolidation, management buyouts, spin-offs, recapitalizations, and cross-border investments. Within mergers and acquisitions, the firm invests in strategic mergers, growth through acquisitions, going public via a reverse merger, and strategic divestures. For recapitalizations, it targets family owned enterprise considering whole or partial exit and balance sheet restructuring. The firm also co-invests in buyout transactions. For its growth stage investments, it allocates 20 percent to startups, 40 percent to expansion, and 40 percent to mezzanine. The firm targets companies operating in information technology infrastructure, wireless communications entertainment and contents, franchising, cement, software, electricity, food and beverage, machinery, game software, chemical, paper manufacture, and automobile parts industries. For industries concentration, it sets 40 percent to information technology infrastructure focusing on security, application service provider, and e-commerce solutions; 30 percent to contents, focusing on education, game, and animation; and 30 percent to digital hardware focusing on network and communications equipment, semiconductor, parts and others. The firm also invests in infrastructure, environment, manufacturing, enzyme, biotechnology, and healthcare sectors. It also makes secondary investments. The firm primarily invests in South Korean medium-sized companies located in Seoul, Gyeonggi, Daegu, Gyeongsangbuk-do, and Chungcheongbuk-do. It prefers to take an active role in management. IMM Investment Corp. was founded in July 1999 and is based in Seoul, South Korea.

OrbiMed is a healthcare-dedicated investment firm, with approximately $5 billion in assets under management. OrbiMed's investment advisory business was founded in 1989 with a vision to invest across the spectrum of healthcare companies: from private start-ups to large multinational companies. OrbiMed manages the Caduceus Private Investments series of venture capital funds and a family of public equity investment funds.

Fidelity is a privately owned investment manager. It also provides IRAs, 401(k) rollovers, annuities, discount brokerage services, retirement services, estate planning, wealth management, securities execution and clearance, and life insurance services to its clients. Fidelity provides its services to individual investors, businesses, financial advisors, and institutions. It manages equity, fixed income, and balanced mutual funds. Fidelity invests in the public equity and fixed income markets across the globe. It conducts in-house research to make its investments. Fidelity operates as a subsidiary of FMR LLC. It began operation in 1946, with its headquarters in Boston in Massachusetts.